Skip to main content

Month: December 2020

EPH European Property Holdings Ltd announces the successful closing of the acquisition QBC 1,2 & 7 in Vienna, Austria

30 December 2020, Road Town, Tortola, BVIIn August 2019, EPH European Property Holdings Ltd. signed the forward purchase transaction regarding the acquisition of prestigious QBC 1 & 2 in Vienna, Austria from the joint venture partners UBM Development (66%) and S IMMO (34%). The closing now took place on December 29, 2020.The Closing includes the office properties QBC 1 & 2 with a leasable area of 38,700 sqm as well as QBC 7, the underground car park with 583 parking spaces (total of almost 680 parking spaces) which have been successfully developed by UBM Development in the past 2 years. QBC 1 & 2 are currently one of the most sought-after office locations in Vienna. This shows the demand for high-quality office space in a prime location remains high. “The project was completed without delays despite two lockdowns,”...

Continue reading

Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it is commencing a study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at the Toronto Institute of Pharmaceutical Technology (“TIPT”) by Dr. Alexander MacGregor, a key scientific advisor to the Company.The study will focus on formulating, manufacturing and clinical bioavailability testing of rapid onset psilocybin dosage forms that could be used in future efficacy clinical trials by both Pure Extracts and its pharmaceutical customers. Clinical batch manufacturing, packaging...

Continue reading

Private Placement Markets to begin Offering SBA Loan Products in January 2021

Beginning in January of 2021, Private Placement Markets will begin offering the following SBA Loan Products Nationwide: • SBA Small Loan 7(a):o Loans up to $350,000 USDo For Businesses & Real Estateo Close in 5-10 Business Days• SBA Standard 7(a):o Loans up to $5M USDo For Businesses & Real Estateo Close in 5-10 Business Days• SBA Express:o Loans up to $350,000 USDo Business & Real Estateo Close within 36 hours• Export Express:o Loan up to $500,000 USDo For business lines of credit up to $500,000 USDo Close in 24-hours• Export Working Capital:o Loans up to $5M USDo For Businesses that can generate export sales and need additional working capital to support sales.o Close in 5-10 Business Days• International Trade:o Loans up to $5M USDo Provides long-term financing to businesses that are expanding because of growing export...

Continue reading

Clean Power Capital Announces Appointment of Amp Energy Founder & CEO Dave Rogers to the PowerTap Advisory Board

VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”). The Company is pleased to appoint Mr. Dave Rogers, Founder & CEO of Amp Energy (“Amp”) to the advisory board of PowerTap Hydrogen Fueling Corp. (“PowerTap”). As previously announced on October 28, 2020, the Company invested in PowerTap as part of its investment strategy in the hydrogen sector.Amp is an energy transition platform company. Founded in 2009, Amp has become one of the leading global renewables companies having successfully developed and built over 1.8 gigawatts renewable generation projects, hybrid generation plus battery storage projects, and stand-alone battery storage projects around the world, alongside a further 2.0 GW of generation...

Continue reading

Gold Plus Mining Acquires Strategic Mineral Claims Contiguous to Benchmark Metal’s “Lawyers” Gold and Silver Project

VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — GOLD PLUS MINING INC. (“Gold Plus” or the “Company”) (CSE :GPMI) (OTC: GPMNF) (FSE: 1I3) is pleased to announce that it has entered into an agreement to acquire highly prospective mineral claims (the “Lawyers North Property”) in BC’s famous “Golden Horseshoe” region contiguous to Benchmark Metal’s (BNCH – TSX.V) “Lawyers” Gold and Silver project that recently reported drilling intercepts of 2,360 g/t silver and 11.30 g/t gold over a 1 meter interval as well as 1.44 g/t gold equivalent over 102 meters.Gold Plus’s new Lawyers North mineral claims cover approximately 7,307 acres (2,957 hectares) and when combined with the Company’s existing Lawyers East and West mineral claims cover a total of approximately 15,957 acres. Both GPMI claim groups are on trend with several mines...

Continue reading

Northfield Bank Furthering Commitment to Serve Its Customers and Communities

WOODBRIDGE, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) — Northfield Bank, a wholly-owned subsidiary of Northfield Bancorp, Inc. (NASDAQ: NFBK), announced today that it will again participate in the Paycheck Protection Program (PPP) to provide a vital source of capital to its customers and communities. Northfield also announced that it has dedicated resources to assist small businesses with ten or less employees and businesses located in low-to-moderate income areas in applying for the next round of PPP funding.Steven M. Klein, President and CEO of Northfield Bank stated, “It is critical that our local small businesses have access to this important source of funding, and we at Northfield are committed to doing everything we can to help them navigate the application process.” Mr. Klein continued, “I’m proud that the Northfield team, including...

Continue reading

Golden Sky Closes Financing

VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — Golden Sky Minerals Corp. (AUEN.V) (the “Company” or “Golden Sky”) is pleased to announce that, subject to regulatory approval, it has closed their private placement financing consisting of Hard Dollar Units and Flow-Through Units, for total gross proceeds of $1,157,750.   Both offerings received support from strategic accredited investors.The Company has closed on 362,500 non-flow-through Units for gross proceeds of $145,000 (the “Units”), each Unit priced at $0.40 and consisting of 1 common share of the Company and 1 common share purchase warrant (the “Unit Warrants”), each Unit Warrant being exercisable for an additional common share of the Company at $0.75 for 24 months from closing, subject to the right of the Company to accelerate the exercise period should, after...

Continue reading

iRhythm Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.iRhythm’s management is scheduled to present on Tuesday, January 12, 2021 at 2:50 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.irhythmtech.com.About iRhythm Technologies, Inc.iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that...

Continue reading

iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption

International Multi-Center Study to Commence January 2021University of Louisville’s Trial on IORT for Large Brain Lesion Treatments AcceleratingFirst European Patient Treated for Brain Metastasis with Xoft IORT SystemNASHUA, N.H., Dec. 29, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the appointment of Santosh Kesari, MD, PhD, a world-renowned neuro-oncologist, as Principal Investigator of its International multi-center clinical trial evaluating the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® as the sole radiation therapy to treat recurrent glioblastoma (GBM) following surgical excision of the malignancy. The study is planned to commence in January 2021 at leading academic institutions and community hospitals...

Continue reading

Eve & Co Announces Share Consolidation

TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) — Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that it has filed articles of amendment to consolidate the Company’s issued and outstanding common shares on the basis of one (1) new common share for every ten (10) existing common shares (the “Consolidation”).As a result of the Consolidation, the 287,867,172 common shares issued and outstanding prior to the Consolidation have been reduced to approximately 28,786,717 common shares (disregarding the treatment of any resulting fractional common shares). Each shareholder’s percentage ownership in the Company and proportional voting power remains unchanged after the Consolidation, except for minor changes and adjustments resulting from the treatment of any resulting fractional common shares.The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.